Cartesian Therapeutics Inc (NAS:RNAC)
$ 36.39 0.62 (1.73%) Market Cap: 647.60 Mil Enterprise Value: 543.60 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 51/100

Q1 2023 Selecta Biosciences Inc Earnings Call Transcript

May 04, 2023 / 12:30PM GMT
Release Date Price: $32.1 (-6.96%)
Operator

Good morning, and thank you for joining the Selecta Biosciences First Quarter 2023 Earnings Call. (Operator Instructions) I would now like to turn the call over to Blaine Davis, Chief Financial Officer at Selecta. Please go ahead.

Blaine T. Davis
Selecta Biosciences, Inc. - CFO

Thank you, and good morning, everyone. Welcome to our first quarter 2023 financial results and business update conference call. The press release reporting our financial results is available in the Investor and Media section of Selecta's website at www.selectabio.com, and in our quarterly report on Form 10-Q for the quarter ended March 31, 2023, which was filed earlier this morning with the Securities and Exchange Commission of the SEC.

Joining me on today's call are Carsten Brunn, President and Chief Executive Officer; Kate Kishimoto, Chief Scientific Officer; and Peter Traber, our Chief Medical Officer.

During today's call, we will be making certain forward-looking statements, including, without

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot